Polio Vaccines Market Latest Trends, Future Strategies And Growth Forecast Till 2030
Polio is a highly contagious viral illness that primarily affects young children and can cause permanent paralysis or death. The World Health Organization (WHO) considers polio to be one of the most serious public health emergencies in the world, and the global eradication of polio has been a top priority for decades. The polio vaccine is considered to be one of the most effective and safe vaccines in the world, and is the primary tool in the fight against the disease.
The global Polio Vaccines Market is expected to reach over $4.5 billion by 2023, growing at a compounded annual growth rate (CAGR) of over 8% from 2018 to 2023.
This growth is largely driven by the increasing demand for polio vaccines, as well as the increasing investment in research and development of new and improved polio vaccines. The Polio Vaccines Market is segmented into two main categories: inactivated polio vaccine (IPV) and oral polio vaccine (OPV). IPV is the most commonly used polio vaccine, and is given as an injection.
It is considered to be the safest and most effective polio vaccine, and is recommended by the WHO for use in routine immunization programs. OPV, on the other hand, is a live-attenuated vaccine that is given orally. It is less expensive and easier to administer than IPV, but it carries a small risk of causing vaccine-associated paralytic polio (VAPP).
The demand for Polio Vaccines Market is increasing due to a number of factors, including the continued threat of polio outbreaks, the increasing number of developing countries implementing routine immunization programs, and the increasing recognition of the need for comprehensive polio control and eradication efforts. In addition, the increasing investment in research and development of new and improved polio vaccines is driving the growth of the market.

Comments
Post a Comment